01-Oct-16 A Chinese government investigation has revealed that more than 80% of the data used in clinical trials of new drugs have been "fabricated". The investigation, led by the SFDA, looked at data from 1,622 clinical trials. The SFDA found that the suspect data failed to meet analysis requirements, were incomplete, or totally non-existent. [image: Plavevski / Shutterstock / Science Alert]

28-Sep-16 With the active ingredients in Traditional Chinese Medicine (TCM) now far better understood than ever before, a new range of hybrid TCM/Western treatments are wooing even the most cynical with their efficacy and lack of side-effects. Advances in research and development have enabled companies to integrate many of TCM's treatments and protocols with the latest technology and medical understanding. [image: HKTDC Research]

21-Sep-16 SK has signed an MOU with Korea University on the development of the 'Aibril' Infectious Disease AI Diagnosis Service, based on Watson. This will be a world first, as up to now AI-based medical services have been mainly limited to diagnosing cancers. No-one has yet provided AI medical services for infectious diseases such as Middle East Respiratory Syndrome and Cholera. [image: Business Korea]

19-Sep-16 With China's demographic shifting towards an ever-higher ratio of citizens aged 60-plus, elder-friendly wearables are seen as a key means of monitoring the health and whereabouts of this affluent, yet vulnerable, sector of contemporary society. In the elderly sector, wearables tend to be either tracking devices or fall alarms. [image: HKTDC Research]

13-Sep-16 Intermountain Precision Genomics of the US and Singapore-based Asia Genomics are joining forces to deliver personalized medicine. First up is a test in Southeast Asia. Under the collaboration deal, the first for Intermountain outside the US, the firms are contracting to offer ICG100 testing. [image: Healthcare IT News]